openPR Logo
Press release

StemGenex™ Offers Therapy for Parkinson’s Disease

04-05-2012 04:48 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: StemGenex™

Treatment for U.S. citizens battling Parkinson’s disease is closer than most people think.

La Jolla, CA, April 03, 2012 -- Parkinson's disease is becoming plague-like. One million Americans currently suffer from the disease, resulting in 25 billion dollars spent on medical research and treatment annually. According to the National Parkinson's Foundation, each patient spends an average of $2,500 a year for medications. Estimates of costs of medical care, disability payments and lost income exceed $5.6 million annually. Exploratory surgical therapy costs about $100,000.00. Now, one US based company is offering access to adult stem cell therapy for those with Parkinson's diseases. The cost for stem cell therapy, in comparison to the current alternatives, is very reasonable.

StemGenex ( is helping people with Parkinson's improve their lives through the use of adipose (fat) stem cells. According to The Guardian, brain cells that normally die when a person succumbs to Parkinson's disease now can be regenerated with the use of human stem cells. Parkinson's disease takes hold of functioning brains cells which produce dopamine. This causes tremors, rigidity and slowness of movement, exhaustion, severe pain, and depression. Now, because of companies like StemGenex, patients have an alternative approach for slowing the progression of this untreatable disease.

“There isn’t a cure for Parkinson’s disease.” Says Rita Alexander of StemGenex. “But, over the last five years we have worked with scientists and physicians to find a stem cell treatment protocol that would help alleviate many of the symptoms associated with this devastating neurological disorder. We are now establishing a scientific study to document the responses patients experience following adult stem cell treatment. Parkinson’s patients are eager to participate in this study. In the meantime, we find that our patients who seek stem cell therapy have a reduction in Parkinson’s related symptoms and experience a superior lifestyle than patients who chose not to use stem cell therapy. Plus, according to the LA Times, the Vatican agrees stem cell therapy and research plays a constructive role in various areas of medical research.”

The Michael J Fox Foundation currently has a diverse portfolio of embryonic, fetal and adult stem cell research that enables a limited comparison of cell sources and techniques. The foundation has invested over 5.8 million, in the past, to fifteen projects surrounding the various areas of stem cell research, which includes adult stem cells. StemGenex currently offers access to adult stem cells as therapy for people looking to alleviate the primary symptoms of Parkinson’s. Adult stem cells propose no ethical or religious conflicts. The use of adult stem cells in therapy is not controversial, as these cells are derived from the patient’s own adult tissue samples rather than destroyed human embryos.

Evaluation for treatment through StemGenex™ by experienced stem cell physicians is easy and uncomplicated. People interested in learning more about stem cell therapy simply need to call the company at 800.609.7795 or completing a request for information form. A Patient Advocate will address questions and provide individuals with further detailed information. StemGenex™ also offers access to treatment for Alzheimer’s, Autoimmune diseases, Multiple Sclerosis, and COPD. StemGenex™ is a division of the International Stem Cell Institute (ISCI).

The Michael J Fox Foundation currently has a diverse portfolio of embryonic, fetal and adult stem cell research that enables a limited comparison of cell sources and techniques.

Rita Alexander
The Human Repair Kit™
La Jolla, CA 92037

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release StemGenex™ Offers Therapy for Parkinson’s Disease here

News-ID: 216739 • Views: 2138

More Releases for Stem

Stem Cell Industry - Exclusive Interviews with Stem Cell Industry Executives
MarketResearchReports.Biz adds “Global Stem Cell Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Stem Cell and the growth estimates for the forecasted period. Stem cell research has been in process for over five decades. Stem cells have a unique ability to divide and replicate repeatedly, as well as an “unspecialized” nature that allows them to differentiate into a
Autologous Stem Cell and Non-Stem Cell Based Therapies Market
Autologous stem-cell transplantation (also known as autogeneic, autogenic, or autogenous stem-cell transplantation or auto-SCT) is the autologous transplantation of stem cells—which is, transplantation in which the undifferentiated cells or stem cells (cells from which other types of cells develop) are taken from a person, accumulated, and given back to the same person later. Even though it is most often executed by means of hematopoietic stem cells (antecedent of cells that
Global Stem Cell Storage Market By Product Type - Umbilical Cord Blood Stem Cell …
Researchmoz added Most up-to-date research on "Global Stem Cell Storage Market By Product Type - Umbilical Cord Blood Stem Cell, Embryonic Stem Cell & Adult Stem Cell" to its huge collection of research reports. In this report, the global Stem Cell Storage market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between
Stem Cells Industry Forecast Report 2017-2022 has announced the addition of the “United States Stem Cells Market Report 2017” The report focuses on United States major leading players with information such as company profiles, product picture and specification. Geographically, this report splits the United States market into seven regions: The West, Southwest, The Middle Atlantic, New England, The South and The Midwest. with sales (volume) , revenue (value) , market share and growth rate of Stem
Proceeding of Stem Cells in Asia-Pacific Stem Cell Market.
Asia-Pacific Stem Cell Market research report, published by Market Data Forecast estimates that the market is growing with a CAGR of 15.5% to reach USD 7.15 billion by 2021, from USD 3.48 billion in 2016, which amounts to a cumulative growth of USD 3.67 billion. Stem cells are those cells that are maintained for a long time by remaining undifferentiated and sustained proliferation in a few parts of the body. Stem
STEM Summer Camp 2017
Join Mental Fitness for our second annual Summer of STEAM camp in South Fulton County. Our campers continue their learning in a fun and engaging way while still enjoying the summer! Your student will experience a half day of hands-on project based learning and a half day of good old fashion summer fun. High level concepts like electricity and magnetism, computer coding, environmental projects and more.